FC03.fr.i
Checkpoint
PascalFrancis
Racine
Checkpoint
PascalFrancis
Exploration
Accueil
Racine
Racine

La maladie de Parkinson au Canada (serveur d'exploration) - Checkpoint (PascalFrancis)

Index « FC03.fr.i » - entrée « Sélégiline »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Sélectivité < Sélégiline < Sénescence  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
000094 (2013) Mee-Sook Song [Canada] ; Dmitriy Matveychuk [Canada] ; Erin M. Mackenzie [Canada] ; Maryana Duchcherer [Canada] ; Darrell D. Mousseau [Canada] ; Glen B. Baker [Canada]An update on amine oxidase inhibitors: Multifaceted drugs
000B63 (2000) Andis Klegeris [Canada] ; Patrick L. Mcgeer [Canada]R-(-)-deprenyl inhibits monocytic THP-1 cell neurotoxicity independently of monoamine oxidase inhibition
000C37 (1999) K. Kitani [Japon] ; S. Kanai [Japon] ; G. O. Ivy [Canada] ; M. C. Carrillo [Argentine]Pharmacological modifications of endogenous antioxidant enzymes with special reference to the effects of deprenyl : a possible antioxidant strategy
000C45 (1999) D. L. Gelowitz [États-Unis] ; I. A. Paterson [Canada]Neuronal sparing and behavioral effects of the antiapoptotic drug, (-)deprenyl, following kainic acid administration
000D29 (1998) P. H. Yu [Canada] ; X. Zhang [Canada] ; D. M. Zuo [Canada] ; C. T. Lai [Canada] ; K. Tieu [Canada] ; B. A. Davis [Canada] ; A. A. Boulton [Canada]Aliphatic N-methylpropargylamines as potential neurorescue agents
000D53 (1997) I. H. Richard [États-Unis] ; R. Kurlan [États-Unis] ; C. Tanner [États-Unis] ; S. Factor [États-Unis] ; J. Hubble [États-Unis] ; O. Suchowersky [Canada] ; C. Waters [États-Unis]Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease
000D60 (1997) C.-T. Lai [Canada] ; P. H. Yu [Canada]R(-)-deprenyl potentiates dopamine induced cytotoxicity toward catecholaminergic neuroblastoma SH-SY5Y cells
000D64 (1997) S. Rohatagi [États-Unis] ; J. S. Barrett [États-Unis] ; K. E. Dewitt [États-Unis] ; D. Lessard [Canada] ; R. J. Morales [États-Unis]Pharmacokinetic evaluation of a selegiline pulsatile oral delivery system
000D77 (1997) C. Thiffault [Canada] ; L. Lamarre-Theroux [Canada] ; R. Quirion [Canada] ; J. Poirier [Canada]L-Deprenyl and MDL72974 do not improve the recovery of dopaminergic cells following systemic administration of MPTP in mouse
000E16 (1996) W. G. Tatton [Canada] ; R. M. E. Chalmers-Redman [Canada]Modulation of gene expression rather than monoamine oxidase inhibition : (-)-Deprenyl-related compounds in controlling neurodegeneration
000E67 (1995) C. Thiffault [Canada] ; N. Aumont ; R. Quirion [Canada] ; J. PoirierEffect of MPTP and L-deprenyl on antioxidant enzymes and lipid peroxidation levels in mouse brain
000E88 (1994) E. Scarr [Canada] ; D. M. Wingerchuk ; A. V. Juorio ; I. A. PatersonThe effects of monoamine oxidase B inhibition on dopamine metabolism in rats with nigro-striatal lesions
000F00 (1994) P. H. Yu [Canada]Pharmacological and clinical implications of MAO-B inhibitors
000F36 (1993) M. Takada [Canada] ; T. Sugimoto ; T. Hattori [Canada]MPTP neurotoxicity to cerebellar Purkinje cells in mice
000F68 (1992) M. Schulzer [Canada] ; E. Mark ; D. B. CalneThe antiparkinson efficacy of deprenyl derives from transient improvement that is likely to be symptomatic
001015 (1991) W. G. Tatton [Canada] ; C. E. GreenwoodRescue of dying neurons : a new action for deprenyl in MPTP parkinsonism
001032 (1991) O. S. Kofman [Canada]Deprenyl : protective vs. symptomatic effect
001146 (1987) A. E. LangManipulating the dopaminergic system in Parkinson's disease

List of associated Author.i

Nombre de
documents		Descripteur
3P. H. Yu
2C. Thiffault
2I. A. Paterson
2J. Poirier
2R. Quirion
2W. G. Tatton
1A. A. Boulton
1A. E. Lang
1A. V. Juorio
1Andis Klegeris
1B. A. Davis
1C. E. Greenwood
1C. T. Lai
1C. Tanner
1C. Waters
1C.-T. Lai
1D. B. Calne
1D. L. Gelowitz
1D. Lessard
1D. M. Wingerchuk
1D. M. Zuo
1Darrell D. Mousseau
1Dmitriy Matveychuk
1E. Mark
1E. Scarr
1Erin M. Mackenzie
1G. O. Ivy
1Glen B. Baker
1I. H. Richard
1J. Hubble
1J. S. Barrett
1K. E. Dewitt
1K. Kitani
1K. Tieu
1L. Lamarre-Theroux
1M. C. Carrillo
1M. Schulzer
1M. Takada
1Maryana Duchcherer
1Mee-Sook Song
1N. Aumont
1O. S. Kofman
1O. Suchowersky
1Patrick L. Mcgeer
1R. J. Morales
1R. Kurlan
1R. M. E. Chalmers-Redman
1S. Factor
1S. Kanai
1S. Rohatagi
1T. Hattori
1T. Sugimoto
1X. Zhang

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/FC03.fr.i -k "Sélégiline" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/FC03.fr.i  \
                -Sk "Sélégiline" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    indexItem
   |index=    FC03.fr.i
   |clé=    Sélégiline
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022